Great Britain

Coronavirus BREAKTHROUGH: UK secures early access to 90 million doses of vaccine candidate

Coronavirus BREAKTHROUGH: UK secures early access to 90 million doses of COVID-19 vaccine candidates

Coronavirus BREAKTHROUGH: UK secures early access to 90 million doses of COVID-19 vaccine candidates (Image: EXPRESS)

Potential vaccine Novavax will complete its Phase 3 clinical trial in the UK. If the vaccines are proven to be safe and effective they could be delivered to the UK by the middle of next year.

There are now plans to manufacture the COVID-19 vaccine in the UK and gain access to 60 million doses.

The UK will also co-fund a global clinical trial with the Janssen Pharmaceutical Companies of Johnson & Johnson which will account for the other 30 million doses.

Priority would be given to groups such as health and social care workers and those with conditions that put them at higher risk from the coronavirus.

With the two new deals, the UK has secured access to six vaccine candidates.

MORE TO FOLLOW...

Football news:

Barcelona's Interest in Isak Increased after Koeman's appointment. Larsson has a high opinion of the player (Mundo Seportivo)
Manuel Pellegrini: When you play against Real Madrid and var, it's too much
PSV and Porto are Interested in Barcelona midfielder PUC. He doesn't want to leave the club
Puyol about Barcelona: If we want to win the championship, we need to perform very well
Schalke sacked Wagner. The team has not won the Bundesliga since January
Iacini on 3:4 with Inter: Even a draw would be an unfair result, given how many chances Fiorentina created
Ramos Pro 3:2 with Betis: the Referee tried his best and didn't do anything intentionally